Evidence map›Paper›PMID 32004412›Full record

ArticleClinical and translational science2020

Approach to High Volume Enrollment in Clinical Research: Experiences from an All of Us Research Program Site.

Titilayo O Ilori, Emma Viera, Jillian Wilson, Francisco Moreno, Usha Menon, John Ehiri, Rachele Peterson, Tejo Vemulapalli, Sara C StimsonRiahi, Cecilia Rosales and 7 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Titilayo O IloriRenal Section, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.
Emma VieraDivision of Public Health Practice and Translational Research, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Jillian WilsonDepartment of Internal Medicine, Kansas University Medical Center, Kansas City, Kansas, USA.
Francisco MorenoDepartment of Psychiatry, College of Medicine, University of Arizona, Tucson, Arizona, USA.
Usha MenonCollege of Nursing, University of South Florida, Tampa, Florida, USA.
John EhiriDepartment of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Rachele PetersonUniversity of Arizona Health Sciences, Tucson, Arizona, USA.
Tejo VemulapalliDepartment of Medicine, College of Medicine Tucson, University of Arizona, Tucson, Arizona, USA.
Sara C StimsonRiahiDepartment of Medicine, College of Medicine Phoenix, University of Arizona, Tucson, Arizona, USA.
Cecilia RosalesDivision of Public Health Practice and Translational Research, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Elizabeth CalhounDivision of Community, Environment, and Policy of the UA Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Amanda SokanDivision of Public Health Practice and Translational Research, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
Jason H KarnesDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
Eric ReimanBanner Alzheimer's Institute, Phoenix, Arizona, USA.
Akinlolu OjoKansas University Medical Center, Kansas City, Kansas, USA.
Andreas TheodorouDepartment of Pediatrics, University of Arizona, Tucson, Arizona, USA.
Tammy OjoDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Kansas University Medical Center, Kansas City, Kansas, USA.
University of Arizona · USUniversity Medical Center · USArizona Science Center · USBanner Alzheimer’s InstituteBanner - University Medical Center Tucson · USBoston Medical Center · USUniversity of Kansas Medical Center · USUniversity of South Florida · US

Funding

University of Arizona-Banner Health All of Us Research Program OT2OD026549 · OD · UNIVERSITY OF ARIZONA · PI MORENO, FRANCISCO A, REIMAN, ERIC MICHAEL · 2018 to 2023
$78.9M
Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
NIA NIH HHS P30 AG019610NIH HHS OT2 OD026549
6 · The paper itself

Abstract

Clinical trials and cohort studies are required to meet target recruitment of study participants within stipulated timelines, especially when the priority is to include populations traditionally unrepresented in biomedical research. By the third quarter of 2019, the University of Arizona-Banner Health Provider Organization (UA-Banner HPO) has enrolled > 30,000 core participants into the All of Us Research Program (AoURP), the research cohort of the Precision Medicine Initiative. The majority of enrolled participants meet the criteria for individuals under-represented in biomedical research. The enrollment goals were calculated based on a target of 20,000 as set by the National Institutes of Health and our health provider organization achieved enrollment numbers between 17% and 86% above the targeted daily enrollment. We evaluated enrollment methods and challenges to enrollments encountered by the UA-Banner Health Provider Organization into the AoURP. Challenges to enrollment centered around the need for high-touch engagement methods, time investment necessary for stakeholder inclusion, and the use of purely digital enrollment methods especially in populations under-represented in biomedical research. These challenges occurred at the level of the individual, provider, institutions, and community, and cumulatively impacted participant enrollment. Successful strategies for engagement and enrollment leveraged provider partners as advocates for the program. For high-volume enrollment in clinical research, it is important to engage leaders in the healthcare setting, patient providers, and tailor engagement and enrollment to potential participant needs. We emphasize the need for precision engagement and enrollment methods tailored to individual needs.

Indexed as

Patient SelectionBiomedical ResearchClinical Trials as TopicCommunity ParticipationHumansPatient ParticipationPrecision MedicineUnited States

Identifiers

PMID32004412
PMCPMC7359931
OpenAlexW3003612432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.